Evidence map›Paper›PMID 40378834›Full record

ArticleNeuron2025

Opioid-driven disruption of the septum reveals a role for neurotensin-expressing neurons in withdrawal.

Rhiana C Simon, Weston T Fleming, Brandy A Briones, Marta Trzeciak, Pranav Senthilkumar, Kentaro K Ishii, Madelyn M Hjort, Madison M Martin, Koichi Hashikawa, Andrea D Sanders and 2 more

Abstract read
In one paragraph

Article in Neuron, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. A Neurotensin Brake on Exploratory Drive under Persistent Threat.bioRxiv : the preprint server for biology · 2026
    Article
  2. Multimodal classification of neurons in the lateral septum.bioRxiv : the preprint server for biology · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors.

Rhiana C SimonCenter for the Neurobiology of Addiction, Pain, and Emotion (NAPE), University of Washington, Seattle, WA 98195, USA; Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA 98195, USA.
Weston T FlemingCenter for the Neurobiology of Addiction, Pain, and Emotion (NAPE), University of Washington, Seattle, WA 98195, USA; Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA 98195, USA; Howard Hughes Medical Institute, University of Washington, Seattle, WA 98195, USA.
Brandy A BrionesCenter for the Neurobiology of Addiction, Pain, and Emotion (NAPE), University of Washington, Seattle, WA 98195, USA; Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA 98195, USA.
Marta TrzeciakCenter for the Neurobiology of Addiction, Pain, and Emotion (NAPE), University of Washington, Seattle, WA 98195, USA; Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA 98195, USA.
Pranav SenthilkumarCenter for the Neurobiology of Addiction, Pain, and Emotion (NAPE), University of Washington, Seattle, WA 98195, USA.
Kentaro K IshiiCenter for the Neurobiology of Addiction, Pain, and Emotion (NAPE), University of Washington, Seattle, WA 98195, USA; Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA 98195, USA.
Madelyn M HjortCenter for the Neurobiology of Addiction, Pain, and Emotion (NAPE), University of Washington, Seattle, WA 98195, USA; Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA 98195, USA.
Madison M MartinCenter for the Neurobiology of Addiction, Pain, and Emotion (NAPE), University of Washington, Seattle, WA 98195, USA; Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA 98195, USA.
Koichi HashikawaCenter for the Neurobiology of Addiction, Pain, and Emotion (NAPE), University of Washington, Seattle, WA 98195, USA; Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA 98195, USA.
Andrea D SandersCenter for the Neurobiology of Addiction, Pain, and Emotion (NAPE), University of Washington, Seattle, WA 98195, USA.
Sam A GoldenCenter for the Neurobiology of Addiction, Pain, and Emotion (NAPE), University of Washington, Seattle, WA 98195, USA; Department of Neurobiology and Biophysics, University of Washington, Seattle, WA 98195, USA.
Garret D StuberCenter for the Neurobiology of Addiction, Pain, and Emotion (NAPE), University of Washington, Seattle, WA 98195, USA; Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA 98195, USA; Department of Pharmacology, University of Washington, Seattle, WA 98195, USA. Electronic address: gstuber@uw.edu.

Funding

University of Washington Center of Excellence in Opioid Addiction ResearchP30DA048736 · NIDA · UNIVERSITY OF WASHINGTON · PI Michael R. Bruchas · 2019 to 2026
$13.0M
Neural circuit elements that orchestrate cue-reward associationsR37DA032750 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Garret D Stuber · 2017 to 2026
$4.5M
Lateral Hypothalamic Circuits for Feeding and ReinforcementR01DA038168 · NIDA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI STUBER, GARRET D · 2014 to 2025
$4.0M
Integrative single-cell spatial transcriptomic, anatomical, and functional profiling of brain-wide ensembles engaged by opioid relapseR01DA059374 · NIDA · UNIVERSITY OF WASHINGTON · PI Sam Golden, Liangcai Gu · 2023 to 2026
$3.1M
The impact of early life opioid exposure on the molecular and functional trajectories of septal cell typesR01DA059388 · NIDA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI COREY C HARWELL, Garret D Stuber · 2023 to 2026
$3.1M
Transcriptional, functional, and circuit profiling at single cell resolution of neuronal ensembles engaged by heroin relapseR01DA054317 · NIDA · UNIVERSITY OF WASHINGTON · PI FERGUSON, SUSAN MARIE, STUBER, GARRET D · 2021 to 2025
$2.7M
Disentangling stress-induced transcriptional and functional heterogeneity of the midbrainF31MH117931 · NIMH · UNIVERSITY OF WASHINGTON · PI SIMON, RHIANA CATHERINE · 2019 to 2021
$122k
NIDA NIH HHS P30 DA048736NIDA NIH HHS R01 DA038168NIDA NIH HHS R01 DA054317NIDA NIH HHS R01 DA059374NIDA NIH HHS R01 DA059388NIDA NIH HHS R37 DA032750NIMH NIH HHS F31 MH117931
6 · The paper itself

Abstract

Opioid withdrawal is an intensively aversive experience and often drives relapse. The lateral septum (LS) is a forebrain structure that is important in aversion processing and has been linked to substance use disorders, but which LS cell types contribute to the maladaptive state of withdrawal is unknown. We used single-nucleus RNA sequencing to interrogate cell-type-specific gene expression changes induced by chronic morphine exposure and discovered that morphine globally disrupts LS cell types, but neurotensin-expressing neurons (LS-Nts) are selectively activated by naloxone. Using two-photon calcium imaging and ex vivo electrophysiology, we next demonstrate that LS-Nts neurons receive elevated glutamatergic drive in morphine-dependent mice and remain hyperactivated during withdrawal. Finally, we show that manipulating LS-Nts neurons during opioid withdrawal regulates pain coping and sociability. Together, these results suggest that LS-Nts neurons are a key neural substrate involved in opioid withdrawal and establish the LS as a crucial regulator of adaptive behaviors.

Indexed as

Analgesics, OpioidMorphineMorphine DependenceNeuronsNeurotensinSeptal NucleiSeptum of BrainSubstance Withdrawal SyndromeAnimalsMaleMiceMice, Inbred C57BLNaloxoneNarcotic AntagonistsAnalgesics, OpioidMorphineNaloxoneNarcotic AntagonistsNeurotensinaddictionbehaviorcell typeneurocircuitsneurotensinopioidsoptogeneticsseptumsequencingwithdrawal

Identifiers

PMID40378834
PMCPMC13588143

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.